Abnormal DYRK1A expression is also linked to a raft of malignancies like glioblastoma multiforme [60], gastrointestinal stromal tumors, lung cancer [61], melanoma, and leukemias (AML, AMLK, and ALL) [62]. Here, DYRK1A is linked to acute myeloid leukemia.